$CKDXF Cashflow Statement | Understand Stock

$CKDXF

$0.01 -$0.10 (90.52%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021
Cashflow from operating activities
Interest received
Royalty and license income received
Grant Income
Grant and other income
Payment of lease interest
Payments to suppliers, employees and for research & development and intellectual property costs (inclusive of GST)
Taxes paid to US
Research and development tax incentive scheme credit received in cash
Net cash flows used in operating activities

Cash flow from investing activities:
Purchase of equipment
Proceeds from sale of financial assets
Net cash used in investing activities

Cash flows from financing activities:
Payment of lease liabilities
Net proceeds on issue of shares
Net proceeds on issuance of pre-funded warrants
Net proceeds on issue of pre-funded warrants
Proceeds on issue of shares, net of issuance costs
Net proceeds under the DFA
Net proceeds from DFA
Cash received for ordinary shares issued on exercise of options
Cash received for ordinary shares issued on exercise of investor options
Cash received for ordinary shares issued on exercise of options LTIP
Net cash provided by financing activities

Net (decrease)/increase in cash and cash equivalents
Effects of exchange rate changes on the balance of cash held in foreign currencies
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments